256 related articles for article (PubMed ID: 25859543)
1. High mobility group a proteins as tumor markers.
Pallante P; Sepe R; Puca F; Fusco A
Front Med (Lausanne); 2015; 2():15. PubMed ID: 25859543
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of high mobility group A proteins in lung cancer.
Sarhadi VK; Wikman H; Salmenkivi K; Kuosma E; Sioris T; Salo J; Karjalainen A; Knuutila S; Anttila S
J Pathol; 2006 Jun; 209(2):206-12. PubMed ID: 16521118
[TBL] [Abstract][Full Text] [Related]
3. HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas.
Palumbo A; De Martino M; Esposito F; Fraggetta F; Neto PN; Valverde Fernandes P; Santos IC; Dias FL; Nasciutti LE; Meireles Da Costa N; Fusco A; Ribeiro Pinto LF
Histopathology; 2018 Jun; 72(7):1102-1114. PubMed ID: 29266325
[TBL] [Abstract][Full Text] [Related]
4. Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours.
Franco R; Esposito F; Fedele M; Liguori G; Pierantoni GM; Botti G; Tramontano D; Fusco A; Chieffi P
J Pathol; 2008 Jan; 214(1):58-64. PubMed ID: 17935122
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Mechanisms Leading to Overexpression of HMGA Proteins in Human Pituitary Adenomas.
D'Angelo D; Esposito F; Fusco A
Front Med (Lausanne); 2015; 2():39. PubMed ID: 26137461
[TBL] [Abstract][Full Text] [Related]
6. High Mobility Group A proteins in esophageal carcinomas.
Palumbo Júnior A; Da Costa NM; Esposito F; Fusco A; Pinto LF
Cell Cycle; 2016 Sep; 15(18):2410-3. PubMed ID: 27484584
[TBL] [Abstract][Full Text] [Related]
7. HMGA and Cancer: A Review on Patent Literatures.
De Martino M; Fusco A; Esposito F
Recent Pat Anticancer Drug Discov; 2019; 14(3):258-267. PubMed ID: 31538905
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of
Palumbo Júnior A; de Sousa VPL; Esposito F; De Martino M; Forzati F; Moreira FCB; Simão TA; Nasciutti LE; Fusco A; Ribeiro Pinto LF; Bessa Pereira Chaves C; Meireles Da Costa N
Genes (Basel); 2019 May; 10(5):. PubMed ID: 31096664
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.
Palmieri D; D'Angelo D; Valentino T; De Martino I; Ferraro A; Wierinckx A; Fedele M; Trouillas J; Fusco A
Oncogene; 2012 Aug; 31(34):3857-65. PubMed ID: 22139073
[TBL] [Abstract][Full Text] [Related]
10. Identification of a New Pathway for Tumor Progression: MicroRNA-181b Up-Regulation and CBX7 Down-Regulation by HMGA1 Protein.
Mansueto G; Forzati F; Ferraro A; Pallante P; Bianco M; Esposito F; Iaccarino A; Troncone G; Fusco A
Genes Cancer; 2010 Mar; 1(3):210-24. PubMed ID: 21779448
[TBL] [Abstract][Full Text] [Related]
11. Differential Expression of HMGA1 and HMGA2 in pituitary neuroendocrine tumors.
Portovedo S; Gaido N; de Almeida Nunes B; Nascimento AG; Rocha A; Magalhães M; Nascimento GC; Pires de Carvalho D; Soares P; Takiya C; Faria MDS; Miranda-Alves L
Mol Cell Endocrinol; 2019 Jun; 490():80-87. PubMed ID: 30999005
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells.
Fedele M; Pierantoni GM; Berlingieri MT; Battista S; Baldassarre G; Munshi N; Dentice M; Thanos D; Santoro M; Viglietto G; Fusco A
Cancer Res; 2001 Jun; 61(11):4583-90. PubMed ID: 11389094
[TBL] [Abstract][Full Text] [Related]
13. High-Mobility Group A (HMGA) Proteins and Breast Cancer.
Peluso S; Chiappetta G
Breast Care (Basel); 2010; 5(2):81-85. PubMed ID: 20847819
[TBL] [Abstract][Full Text] [Related]
14. Critical role of HMGA proteins in cancer cell chemoresistance.
D'Angelo D; Mussnich P; Arra C; Battista S; Fusco A
J Mol Med (Berl); 2017 Apr; 95(4):353-360. PubMed ID: 28293697
[TBL] [Abstract][Full Text] [Related]
15. HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents.
Palmieri D; Valentino T; D'Angelo D; De Martino I; Postiglione I; Pacelli R; Croce CM; Fedele M; Fusco A
Oncogene; 2011 Jul; 30(27):3024-35. PubMed ID: 21339738
[TBL] [Abstract][Full Text] [Related]
16. Construction and analysis of cells lacking the HMGA gene family.
Beitzel B; Bushman F
Nucleic Acids Res; 2003 Sep; 31(17):5025-32. PubMed ID: 12930952
[TBL] [Abstract][Full Text] [Related]
17. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
[TBL] [Abstract][Full Text] [Related]
18. The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin.
D'Angelo D; Borbone E; Palmieri D; Uboldi S; Esposito F; Frapolli R; Pacelli R; D'Incalci M; Fusco A
Eur J Cancer; 2013 Mar; 49(5):1142-51. PubMed ID: 23149213
[TBL] [Abstract][Full Text] [Related]
19. HMGA2 Antisense Long Non-coding RNAs as New Players in the Regulation of HMGA2 Expression and Pancreatic Cancer Promotion.
Ros G; Pegoraro S; De Angelis P; Sgarra R; Zucchelli S; Gustincich S; Manfioletti G
Front Oncol; 2019; 9():1526. PubMed ID: 32010621
[No Abstract] [Full Text] [Related]
20. [HMGA proteins and their genes as a potential neoplastic biomarkers].
Balcerczak E; Balcerczak M; Mirowski M
Postepy Biochem; 2005; 51(3):261-9. PubMed ID: 16381170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]